Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2A basic helix-loop-helix transcription factors in human leukemia.

David P LeBrun1

  • 1Department of Pathology, Queen's University, Kingston, Ontario, Canada. lebrun@cliff.path.queensu.ca

Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy.

Leukemia & lymphoma·2022
Same author

Rare presentation of fatal atraumatic splenic rupture in follicular lymphoma.

EJHaem·2022
Same author

Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

The Journal of biological chemistry·2020
Same author

Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterations.

Leukemia & lymphoma·2020
Same author

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples.

Journal of visualized experiments : JoVE·2019
Same author

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.

Diagnostic pathology·2018
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Pediatric acute lymphoblastic leukemia involves E2A gene rearrangements, forming E2A-PBX1 and E2A-HLF fusion proteins. This review examines their role in abnormal gene regulation and leukemogenesis, challenging simplistic models.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Recurrent chromosomal rearrangements involving the E2A gene are implicated in pediatric acute lymphoblastic leukemia (ALL).
  • These rearrangements result in fusion proteins, notably E2A-PBX1 and E2A-HLF, by joining E2A sequences with other genes.
  • Both E2A, PBX1, and HLF proteins function as transcription factors, suggesting a role in abnormal transcriptional regulation in leukemia.

Purpose of the Study:

  • To review the evidence regarding leukemogenesis mediated by E2A-fusion proteins.
  • To explore the mechanistic implications of these fusion proteins in the development of leukemia.
  • To critically evaluate current models of oncogenesis driven by E2A-PBX1 and E2A-HLF.

Main Methods:

  • Literature review of studies on E2A-fusion proteins in pediatric acute lymphoblastic leukemia.

Related Experiment Videos

  • Analysis of evidence related to the function of E2A, PBX1, and HLF transcription factors.
  • Examination of proposed mechanisms of leukemogenesis involving abnormal transcriptional regulation.

    • Main Results:

    • E2A-PBX1 and E2A-HLF are well-characterized fusion proteins resulting from E2A gene rearrangements in pediatric ALL.
    • These fusion proteins are hypothesized to contribute to leukemia by altering the transcription of target genes.
    • Existing models suggesting leukemogenesis solely through excessive transcriptional induction are being challenged by recent findings.

    Conclusions:

    • The role of E2A-fusion proteins in leukemogenesis is complex and may not be fully explained by simple models of transcriptional dysregulation.
    • Further research is needed to elucidate the precise mechanisms by which E2A-PBX1 and E2A-HLF contribute to leukemia development.
    • Understanding these mechanisms is crucial for developing targeted therapies for pediatric acute lymphoblastic leukemia.